Your browser doesn't support javascript.
loading
Joint ENGOT and GOG Foundation requirements for trials with industry partners.
Vergote, Ignace; Coleman, Robert L; Pignata, Sandro; Bookman, Michael A; Marth, Christian; Herzog, Thomas J; Gonzalez-Martin, Antonio; Copeland, Larry J.
Afiliação
  • Vergote I; ENGOT/BGOG and University Hospital Leuven, Gynaecological Oncology, Leuven Cancer Institute, Herestraat 49, 3000 Leuven, Belgium, European Union. Electronic address: Ignace.vergote@uz.kuleuven.ac.be.
  • Coleman RL; GOG-F and Gynecologic Oncology & Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Pignata S; ENGOT/MITO Istituto Nazionale Tumori IRCCS Fondazione Pascale Napoli, Italy.
  • Bookman MA; GOG-F and Gynecologic Oncology Therapeutics, Kaiser Permanente San Francisco, San Francisco, USA.
  • Marth C; ENGOT/A-AGO and Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria.
  • Herzog TJ; GOG-F and Gynecologic Oncology, University of Cincinnati, Cincinnati, Ohio, USA.
  • Gonzalez-Martin A; ENGOT/GEICO and Medical Oncology, Clinica Universidad de Navarra, Madrid, Spain.
  • Copeland LJ; GOG-F and Gynecologic Oncology, Ohio State University Wexner Medical Center and JamesCare Gynecologic Oncology at Mill Run, Columbus, Ohio, USA.
Gynecol Oncol ; 154(2): 255-258, 2019 08.
Article em En | MEDLINE | ID: mdl-31331494

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto Idioma: En Ano de publicação: 2019 Tipo de documento: Article